Caldwell & Orkin’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-65,600
Closed -$1.77M 101
2016
Q4
$1.77M Buy
65,600
+18,100
+38% +$447K 1.12% 34
2016
Q3
$1.06M Sell
47,500
-95,400
-67% -$1.92M 0.73% 43
2016
Q2
$3.05M Buy
+142,900
New +$2.69M 1.32% 26
2014
Q3
Sell
-71,000
Closed -$2.48M 85
2014
Q2
$2.48M Sell
71,000
-22,300
-24% -$732K 1.26% 34
2014
Q1
$2.96M Buy
+93,300
New +$2.59M 1.93% 18

Other funds holding PTEN

Caldwell & Orkin's PTEN Position: Q1 2017 in Review

Caldwell & Orkin sold out of Patterson-UTI (PTEN) in Q1 2017, closing a stake of 65,600 shares — an estimated $1.77M sold.

Caldwell & Orkin first reported a position in PTEN in Q1 2014 and held it in 5 quarters. The position peaked at $3.05M in Q2 2016. 313 funds tracked by Wall St. Rank hold PTEN as of Q1 2017.

  • Caldwell & Orkin reported no remaining Patterson-UTI position as of Q1 2017 after selling out during the quarter.
  • Caldwell & Orkin sold 65,600 Patterson-UTI shares in Q1 2017, an estimated $1.77M.
  • Caldwell & Orkin first reported a position in Patterson-UTI in Q1 2014 and held it in 5 quarters.
  • Caldwell & Orkin's Patterson-UTI position peaked at $3.05M in Q2 2016.
  • 313 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2017.

Based on Caldwell & Orkin's 13F filing for Q1 2017, filed 5 May 2017.